Expression of P-Akt, NFκB and their correlation with human papillomavirus infection in cervical carcinoma

European Journal of Gynaecological Oncology

Volumn 33, Issue 3, 2012, Pages 274-277

  Du, C X ^a   Wang, Y ^a  

^a University of Sience and Technology   (China)

Author keywords

Cervical carcinoma; Human papilloma virus; Nf B; P Akt

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE B; VIRUS DNA;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER TISSUE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; NF-KAPPA B; ONCOGENE PROTEIN V-AKT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHOSPHORYLATION; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84863624484     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Parkin D.M., Pisani P., Ferlay J.: "Global cancer statistics". Carcinoma J. Clin., 1999, 49, 33.
2. rd edition. Beijing: People's Health Press, 2010, 23.
3. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R.J., Sonenshein G.E.: "Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of Ikappa B-alpha that can be inhibited by the tumor suppressor PTEN". Oncogene, 2001, 20, 1287.
4. Malik S.N., Brattain M., Ghosh P.M., Troyer D.A., Prihoda T., Bedolla R., Kreisberg J.I.: "Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer". Clin. Cancer Res., 2002, 8, 1168.
5. Yu L.L., Dai N., Yu H.G., Sun L.M., Si J.M.: "Akt associates with nuclear factor KappaB and plays an important role in chemoresistance of gastric carcinoma cells". Oncol. Rep., 2010, 24, 113.
6. Fresno Vara J.A., Casado E., de Castro J., Cejas P., Belda-Iniesta C., González-Barón M.: "PI3K/Akt signalling pathway and cancer". Carcinoma Treat. Rev., 2004, 30, 193.
7. Ma Y.Y., Wei S.J., Lin Y.C., Lung J.C., Chang T.C., Whang-Peng J. et al.: "PIK3CA as an oncogene in cervical carcinoma". Oncogene, 2000, 19, 2739.
8. Kang S., Bader A.G., Vogt P.K.: "Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic". Proc. Natl. Acad. Sci. USA, 2005, 102, 802.
9. Rao P.H., Arias-Pulido H., Lu X.Y., Harris C.P., Vargas H., Zhang F.F. et al.: "Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma". BMC Cancer, 2004, 6, 4.
10. García M.G., Alaniz L.D., Cordo Russo R.I., Alvarez E., Hajos S.E.: "PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines". Leuk. Res., 2009, 33, 288.
11. Gilmore T.D.: "Introduction to NF-kappaB: players pathways perspectives". Oncogene 2006, 25, 6680.
12. Seheidereit C.: "IkappaB kinase complexes: gateways to NF-kappaB activation and transcription". Oncogene, 2006, 25, 6685.
13. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L. et al.: "Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy". Leukemia, 2003, 17, 590.
14. Cai H.B., Ding X.H., Zhou Y.F., Lie D.M.: "Risk factors for cervical cancer in China: a case-control study". Eur. J. Gynaecol. Oncol., 2008, 1, 72.
15. Kim S.H., Juhnn Y.S., Kang S., Park S.W., Sung M.W., Bang Y.J. et al.: "Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ERK1 2 and PI3K Akt". Cell. Mol. Life Scie., 2006, 63, 930.
16. Menges C.W., Baglia L.A., Lapoint R., McCance D.J.: "Human papillomavirus type 16 E7 Up-regulates AKT Activity through the retinoblastoma protein". Cancer Res., 2006, 66, 5555.
17. Havard L., Rahmouni S., Boniver J., Delvenne P.: "High levels of p105 (NFκB1) and p100 (NFκB 2) proteins in HPV16-transformed keratinocytes role of E 6 and E 7 oncoproteins". Virology, 2005, 331, 357.